Cannabis and cannabinoids for persistent pain?

Over the last 12 months New Zealanders have entered into the debate about cannabis and cannabinoids for medical use. In the coming year we’ll hear even more about cannabis as we consider legalising cannabis for recreational use. There is so much rhetoric around the issue, and so much misinformation I thought it high time (see what I did there?!) to write about where I see the research is at for cannabis and cannabinoids for persistent pain. For the purposes of this blog, I’m going to use the following definitions: Cannabis = the plant; cannabis-based medication = registered extracts (either synthetic or from the plant) in standardised quantities with quality assurance; cannabinoids = substances found in cannabis that may or may not be synthesised into cannabis-based medication. I’m going to divide this post into two: one part is about cannabis and cannabis-based medication for persistent pain; and the other is about cannabis for recreational purposes. Recreational use Cannabis is really popular in New Zealand. Growing up in Gisborne, one of the prime growing regions because of its long, warm summers, cannabis was common. I’ll put my hand on my heart and say I didn’t try it because I was a bit of a nerd and didn’t even try alcohol until I’d left home at 17! Ministry of Health estimates that eleven percent of adults aged 15 years and over reported using cannabis in the last 12 months (defined here as cannabis users). Can...
Source: HealthSkills Weblog - Category: Anesthesiology Authors: Tags: Chronic pain Coping strategies Research Science in practice cannabinoids cannabis medicinal cannabis neuropathic pain persistent pain recreational cannabis Source Type: blogs

Related Links:

Publication date: December 2020Source: Tribology International, Volume 152Author(s): Chong Luo, Yi Xu, Nengyuan Zeng, Tengda Ma, Chenwei Wang, Yuling Liu
Source: Tribology International - Category: Materials Science Source Type: research
Publication date: Available online 2 August 2020Source: Journal of Membrane ScienceAuthor(s): Guang Yang, Zongli Xie, Aaron W. Thornton, Cara M. Doherty, Mingmei Ding, Hang Xu, Marlene Cran, Derrick Ng, Stephen Gray
Source: Journal of Membrane Science - Category: Materials Science Source Type: research
Publication date: Available online 2 August 2020Source: Journal of Psychiatric ResearchAuthor(s): Mostafa Alikhani, Alireza Ebrahimi, Vahid Farnia, Habibolah Khazaie, Farnaz Radmehr, Elahe Mohamadi, Omran Davarinejad, Kenneth Dürsteler-MacFarland, Dena Sadeghi Bahmani, Serge Brand
Source: Journal of Psychiatric Research - Category: Psychiatry Source Type: research
This study included 250 subjects with NAFLD and 500 non-NAFLD controls. Clinical, anthropological and biochemical data were collected. Subjects with body mass index (BMI)>= 25 kg/m2 were taken as obese and subjects with BMI
Source: Journal of the Association of Physicians of India - Category: General Medicine Tags: J Assoc Physicians India Source Type: research
Conclusion: Gastrointestinal side effects being most common side effect of metformin can lead to discontinuation of therapy. So before extensive evaluation of any GI problem in patient on metformin, other methods can be tried like temporary discontinuation, dose titration or proper intake of medicine. These side effects may also occur even after prolonged treatment with metformin. PMID: 32738838 [PubMed - as supplied by publisher]
Source: Journal of the Association of Physicians of India - Category: General Medicine Tags: J Assoc Physicians India Source Type: research
Authors: Maydeo A, Patil G, Dalal A, Thakare S, Iyer A, Patil N Abstract Introduction: Endoscopic Sleeve gastroplasty (ESG) is a novel minimally invasive endoscopic restrictive bariatric procedure. We studied the safety, effectiveness, 6-month weight loss outcomes of ESG. Methods: We prospectively collected data for patients undergoing ESG at a tertiary care referral center. Laboratory investigations were performed preoperatively, and at 6 months post-operatively. Anthropometric measurements were noted pre and post-operatively at a frequency of 3 months for a 6-month follow-up. Patients with BMI ≥28 kg/m2 wh...
Source: Journal of the Association of Physicians of India - Category: General Medicine Tags: J Assoc Physicians India Source Type: research
Esketamine nasal spray (Spravato), taken with an oral antidepressant, is now indicated in adults with major depression with acute suicidal ideation or behavior.Medscape Medical News
Source: Medscape Psychiatry Headlines - Category: Psychiatry Tags: Psychiatry News Source Type: news
Publication date: October 2020Source: LWT, Volume 132Author(s): Xiaohui Jiang, Yuyun Lu, Shao Quan Liu
Source: LWT Food Science and Technology - Category: Food Science Source Type: research
Publication date: Available online 3 August 2020Source: LWTAuthor(s): Yue Chen, Yajie Wang, Leilei Xu, Yanan Jia, Zihan Xue, Min Zhang, Muenduen Phisalaphong, Haixia Chen
Source: LWT Food Science and Technology - Category: Food Science Source Type: research
Publication date: Available online 3 August 2020Source: Food ControlAuthor(s): Siarhei Charapitsa, Svetlana Sytova, Anton Kavalenka, Lidia Sobolenko, Nikolai Kostyuk, Vladimir Egorov, Sergey Leschev, Sergey Vetokhin, Natalia Zayats
Source: Food Control - Category: Food Science Source Type: research
More News: Addiction | Alcoholism | Anesthesiology | Anxiety | Biology | Blogging | Brain | Cancer | Cancer & Oncology | Cardiology | Chemistry | Chronic Pain | Depression | Disability | Fibromyalgia | Fruit | Funding | Heart | Insomnia | Legislation | Men | Neurology | Neuroscience | New Zealand Health | Pain | Physiology | Psychiatry | Science | Sleep Disorders | Sleep Medicine | Study | Women